Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

New mucolipin-1 agonists divulged by Casma Therapeutics

March 4, 2022

Roche divulges new TLR7/8/9 antagonists

March 3, 2022

Kira Pharmaceuticals discovers C5aR antagonists

March 1, 2022

New complement factor B inhibitors identified at Shanghai Meiyue Biotech Development

March 1, 2022

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent TLR7/8/9 antagonists

Feb. 28, 2022

Osteocytic Cx43 hemichannels as new therapeutic target for treating bone loss and osteoporosis

Feb. 25, 2022

Shaanxi Synthetic Pharmaceutical presents new thiobenzopyran compounds

Feb. 22, 2022

Chinese investigators identify Toll-like receptor antagonists

Feb. 22, 2022

"Twin study" of sorts brings insight into arthritis microbiome

Feb. 21, 2022

Shaanxi Synthetic Pharmaceutical divulges new antiarthritic drugs

Feb. 21, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Parabilis takes top spot, pricing largest biopharma IPO at $670M
BioWorld
Less than two months after Kailera Therapeutics Inc. made headlines with biopharma’s largest IPO to date, Parabilis Medicines Inc. has come along and surpassed...